Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 6.

Millrine, David ORCID:, Rice, Christopher M., Fernandez, Javier U. and Jones, Simon A. ORCID: 2023. Tracking the host response to infection in peritoneal models of acute resolving inflammation. Jenkins, B.J., ed. Inflammation and Cancer, Vol. 2691. Methods in Molecular Biology, New York: Springer, pp. 81-95. (10.1007/978-1-0716-3331-1_7)

Millrine, David ORCID:, Jenkins, Robert H ORCID:, Hughes, Stuart T O and Jones, Simon A ORCID: 2022. Making sense of IL-6 signalling cues in pathophysiology. FEBS Letters 596 (5) , pp. 567-588. 10.1002/1873-3468.14201

Twohig, Jason P., Cardus Figueras, Ana, Andrews, Robert, Wiede, Florian, Cossins, Benjamin C., Derrac Soria, Alicia, Lewis, Myles J., Townsend, Michael J., Millrine, David ORCID:, Li, Jasmine, Hill, David G., Uceda Fernandez, Javier, Liu, Xiao, Szomolay, Barbara ORCID:, Pepper, Christopher J., Taylor, Philip R. ORCID:, Pitzalis, Costantino, Tiganis, Tony, Williams, Nigel M. ORCID:, Jones, Gareth W. and Jones, Simon A. ORCID: 2019. Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cells. Nature Immunology 20 , pp. 458-470. 10.1038/s41590-019-0350-0

Gemechu, Y, Millrine, David ORCID:, Hashimoto, S, Prakesh, J, Sanchenkova, K, Metwally, H, Gyanu, P, Kang, S and Kishimoto, T 2018. Humanized cereblon mice reveal two distinct pathways of immunomodulatory drugs. Proceedings of the National Academy of Sciences 115 (46) , pp. 11802-11807. 10.1073/pnas.1814446115

Fernandez, Javier Uceda, Millrine, David ORCID: and Jones, Simon ORCID: 2018. Tracking competent host defence to chronic inflammation: An In Vivo model of peritonitis. Jenkins, Brendan J., ed. Inflammation and Cancer, Vol. 1725. Methods in Molecular Biology, New York, NY: Springer, pp. 65-75. (10.1007/978-1-4939-7568-6_6)

Millrine, David ORCID: and Kishimoto, Tadamitsu 2017. A brighter side to thalidomide: its potential use in immunological disorders. Trends in Molecular Medicine 23 (4) , pp. 348-361. 10.1016/j.molmed.2017.02.006

This list was generated on Sun Jul 21 11:48:40 2024 BST.